CompaniesKeifeRx
KeifeRx logo

KeifeRx

active
Mclean, VA, United States
Founded 2019
Website
About

Tyrosine kinase inhibitors

Areas of Focus

Categories

Small Molecule PharmaceuticalVirginia, DC, DE & Maryland
Clinical Trials (1)
View all

Total Trials

1

As Lead Sponsor

1

As Collaborator

0

Total Enrollment

1,275

By Phase

PHASE3: 1

By Status

NOT_YET_RECRUITING: 1
Clinical Trials Pipeline1 trial
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2021
2022
2023
2024
2025
2026
2027
Today
NCT05143528
Hover over trial bars to see details

Recent Trials

NCT05143528Lead Sponsor
Evaluating the Efficacy and Safety of Nilotinib BE in Subjects With Early Alzheimer's Disease
PHASE3Not yet recruiting
1,275 participants
Started: Feb 1, 2022 · Completed: Jun 1, 2026
Locations (1)
Headquarters
Mclean, VA, United States
Map

Loading map...